Title {1a}	Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia
Trial registration {2a and 2b}	ClinicalTrials.gov register identifier: NCT04775953
Protocol version {3}	Version 3.0, 14 October 2021
Funding {4}	National Institutes of Health (US NIH), Grant: 5UM1Al104681-09
Author details {5a}	Nicholas A. Turner1, Smitha Zaharoff2, Heather King3,4, Scott Evans5, Toshimitsu Hamasaki5, Thomas Lodise6, Varduhi Ghazaryan7, Tatiana Beresnev7, Todd Riccobene8, Rinal Patel8, Sarah B. Doernberg9, Urania Rappo10, Vance G. Fowler Jr1,2, Thomas L. Holland1,2 1Division of Infectious Diseases, Duke University School of Medicine, Durham, NC 2Duke Clinical Research Institute, Durham, NC 3Population Health Sciences and Division of General Internal Medicine, Duke University School of Medicine, Durham, NC 4Durham VA Health Care System, Health Services Research and Development, Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham, NC 5The Biostatistics Center and Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Rockville, MD 6Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY 7Division of Microbiology and Infectious Diseases (DMID), National Institutes of Health (NIH), Bethesda, MD 8AbbVie, Madison, NJ 9Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA 10BiomX, Inc, Branford, CT
Name and contact information for the trial sponsor {5b}	National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, MD 20892 USA
Role of sponsor {5c}	The study sponsor is the NIAID. The Principal Investigator and research team (authors) are responsible for study design, data management, analysis, and writing of any eventual publications.